Boston Scientific lands FDA clearance for new CRT lead delivery system

May 13, 2010 by MassDevice staff

Boston Scientific Corp. wins 510(k) clearance from the Food & Drug Administration for its new Acuity Break-Away lead delivery system for cardiac resynchronization therapy devices.

BSX logo

Boston Scientific Corp. (NYSE:BSX) won 510(k) clearance from the Food & Drug Administration for a new lead delivery system for its cardiac resynchronization therapy devices.

The device is designed to reduce the risks associated with implanting CRT device leads, the wires that conduct electrical signals via blood vessels from a pacemaker or defibrillator into the heart.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp